Literature DB >> 26876699

Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.

Mahmoud F Fathalla1.   

Abstract

Ovarian cancer is a silent killer. There is a need to intensify research efforts on prevention strategies. The causative role of incessant ovulation has been supported by the protective effect of oral hormonal contraceptives. The released follicular fluid in the process of ovulation bathes not only the surface of the ovary but also the fimbrial end of the fallopian tube. Evidence has been accumulating about a fimbrial tubal origin for ovarian high-grade serous carcinoma, and for the potential of opportunistic or elective salpingectomy as an intervention strategy. Alternatively, periodic suppression of ovulation could be beneficial among women who have no need or are not using oral hormonal contraceptives. Rupture of the ovarian follicle releasing the ovum and follicular fluid is a prostaglandin-mediated inflammatory process. It can be stopped by nonsteroidal anti-inflammatory drugs, leading to pharmacologic production of a luteinized unruptured follicle, simulating a normal non-conception cycle with unaltered steroid patterns/levels and cycle length. Non-hormonal periodic interruption of incessant ovulation could be recommended for women who are at high risk of ovarian cancer, but further research is needed to validate the potential of this approach.
Copyright © 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Incessant ovulation; NSAIDs; Ovarian cancer prevention

Mesh:

Substances:

Year:  2016        PMID: 26876699     DOI: 10.1016/j.ijgo.2015.11.006

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Increase of Incidence and Mortality of Ovarian Cancer during 2003-2012 in Jiangsu Province, China.

Authors:  Zhimei Teng; Renqiang Han; Xingyu Huang; Jinyi Zhou; Jie Yang; Pengfei Luo; Ming Wu
Journal:  Front Public Health       Date:  2016-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.